Literature DB >> 27693963

High glucose prevents osteogenic differentiation of mesenchymal stem cells via lncRNA AK028326/CXCL13 pathway.

Boran Cao1, Ning Liu1, Wenbo Wang2.   

Abstract

BACKGROUND: High glucose (HG) often induces unfavorable effects on proliferation and differentiation of mesenchymal stem cells (MSCs). This study aimed to explore potential molecular pathways underlying HG functional mechanism during osteogenic differentiation of MSCs, involving lncRNA AK028326 and CXCL13.
METHODS: Murine bone marrow-derived MSCs were cultured in osteogenic-inducing medium supplemented with high glucose level at 25mM or 5.5mM as normal control. Expression levels of lncRNA AK028326 and CXCL13 were measured by using real-time PCR. The mineralized nodule formation and alkaline phosphatase (ALP) activity were detected after 21 and 7days of incubation respectively. Western blot were also performed to determine the expression of CXCL13 and osteogenic gene markers. Plasmid pcDNAs and small interference RNAs were transfected as indicated for functional analysis of AK028326 and CXCL13.
RESULTS: HG suppressed the expression of AK028326 and CXCL13 in MSCs in a time-dependent manner, and also the mineralization, ALP activity, and osteogenic gene expression, which could be reversed by overexpression of AK028326 or CXCL13. CXCL13 expression was positively regulated by AK028326 at both mRNA and protein levels. Moreover, CXCL13 mediated the positive regulation of AK028326 on osteogenic gene expression in MSCs and MC3T3-E1 cells, mineralization and ALP activity in MSCs and also HG-induced inhibitory effects during MSCs differentiation into osteoblast.
CONCLUSION: HG could inhibit osteogenic differentiation of MSCs via inhibited expression of CXCL13 mediated by lncRNA AK028326, thereby providing new insights into the molecular mechanism of many osteogenesis-related diseases especially for patients with hyperglycemia.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CXCL13; High glucose; LncRNA AK028326; Mesenchymal stem cells; Osteogenic differentiation

Mesh:

Substances:

Year:  2016        PMID: 27693963     DOI: 10.1016/j.biopha.2016.09.058

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

1.  High glucose promotes mineralization via bone morphogenetic protein 4-Smad signals in early stage of osteoblast differentiation.

Authors:  Ayumu Takeno; Ippei Kanazawa; Ken-Ichiro Tanaka; Masakazu Notsu; Keizo Kanasaki; Takamasa Oono; Yoshihiro Ogawa; Toshitsugu Sugimoto
Journal:  Diabetol Int       Date:  2020-08-30

2.  Regulation of osteogenic differentiation by DNA methylation of the dishevelled gene in bone marrow mesenchymal stem cells.

Authors:  Xiaofeng Han; Xinfeng Li; Guibin Zhong; Zude Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 3.  Long Noncoding RNAs: New Players in the Osteogenic Differentiation of Bone Marrow- and Adipose-Derived Mesenchymal Stem Cells.

Authors:  Qiaolin Yang; Lingfei Jia; Xiaobei Li; Runzhi Guo; Yiping Huang; Yunfei Zheng; Weiran Li
Journal:  Stem Cell Rev Rep       Date:  2018-06       Impact factor: 5.739

4.  MiR-155 inhibition alleviates suppression of osteoblastic differentiation by high glucose and free fatty acids in human bone marrow stromal cells by upregulating SIRT1.

Authors:  Bo Qu; Jun He; Zhimou Zeng; Hongsheng Yang; Zhanli Liu; Zongrui Cao; Hua Yu; Wen Zhao; Xianming Pan
Journal:  Pflugers Arch       Date:  2020-04-04       Impact factor: 3.657

5.  Bone Morphogenetic Protein-6 Attenuates Type 1 Diabetes Mellitus-Associated Bone Loss.

Authors:  Jesse F Wang; Ming-Song Lee; Tsung-Lin Tsai; Ellen M Leiferman; Darrin J Trask; Matthew W Squire; Wan-Ju Li
Journal:  Stem Cells Transl Med       Date:  2019-02-19       Impact factor: 6.940

6.  Long noncoding RNAs: a missing link in osteoporosis.

Authors:  Susana Gomes Santos; Maria Inês Almeida; Andreia Machado Silva; Sara Reis Moura; José Henrique Teixeira; Mário Adolfo Barbosa
Journal:  Bone Res       Date:  2019-03-27       Impact factor: 13.567

7.  Impaired Bone Regenerative Effect of Exosomes Derived from Bone Marrow Mesenchymal Stem Cells in Type 1 Diabetes.

Authors:  Yu Zhu; Yachao Jia; Yanmao Wang; Jia Xu; Yimin Chai
Journal:  Stem Cells Transl Med       Date:  2019-02-26       Impact factor: 6.940

8.  Effect of Lactoferrin on the Expression Profiles of Long Non-coding RNA during Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells.

Authors:  Yan Xu; Jing-Jing An; Dina Tabys; Yin-Dan Xie; Tian-Yu Zhao; Hao-Wei Ren; Ning Liu
Journal:  Int J Mol Sci       Date:  2019-09-28       Impact factor: 5.923

Review 9.  Mechanisms of altered bone remodeling in children with type 1 diabetes.

Authors:  Giacomina Brunetti; Gabriele D'Amato; Stefania De Santis; Maria Grano; Maria Felicia Faienza
Journal:  World J Diabetes       Date:  2021-07-15

10.  Potential functions of long non‑coding RNAs in the osteogenic differentiation of human bone marrow mesenchymal stem cells.

Authors:  Xiang Sun; Bo Jia; Xiao-Ling Qiu; Hong-Xing Chu; Zhao-Qiang Zhang; Zhi-Ping Wang; Jian-Jiang Zhao
Journal:  Mol Med Rep       Date:  2018-11-20       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.